Atlas Trials

Study of Protease Inhibitor Regimen Switch in HIV-1 Infected Patients With Undetectable Viral Load to Prove the Non-inferiority of Once Daily Dose Regimen Versus the Current Twice Daily Regimen to Maintain the Viral Load Under the Limit of Detection.

Clinical trial NCT00849160 · COMPLETED

Trial details

NCT number
NCT00849160
Sponsor
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
HIV-1 InfectionHIV Infections
Start date
2009-05-01
Primary completion
2011-06-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.